Most Anticipated Drug Launches of 2023

Letting new drugs into the market is never easy, so only a few entries get passed the strict FDA regulations annually.  Those that do pass, though, have the potential to enrich the current drug market and make it easier for both physicians and patients to get the most out of treatments.  Regarding the types of […]

Novel FDA Drug Approvals in 2022

Coming up with a new drug that can help save lives or at least alleviate the symptoms of patients worldwide is a noble pursuit with a tough road ahead.  Getting a drug approved is justifiably rigorous and arduous, as the lives of people taking the drugs can get significantly affected by them – for better […]

Sustainability in Pharma: How Does it Measure Up?

No expense is too high to test, develop, and distribute a drug thoroughly. After all, we are talking about the health and well-being of humans.  Despite the appearance of drugs as small, easy to mass produce, and relatively inexpensive, developing, testing, and making a drug takes a lot of time, resources, and energy.  As more […]

Cardiovascular Outcomes Trials Answer Long-Asked Questions – But New Questions Arise

The recent American Diabetes Association’s 75th Scientific Sessions in Boston saw the release of data from the ELIXA cardiovascular outcomes trial (CVOT) for lixisenatide (Sanofi/Zealand Pharma’s Lyxumia), the first such trial completed for the GLP-1 receptor agonist drug class. However, it was the publication of the data from the CVOT for sitagliptin (Merck’s Januvia/Ono’s Glactiv), […]

Vigilant Biosciences Announces Agreement with Eurobio for Exclusive Distribution of the OncAlert™ Oral Cancer Risk Assessment System in France, Algeria, Morocco and Tunisia

Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has entered into a three-year exclusive sales and marketing agreement with Eurobio for the distribution of the OncAlert Oral Cancer Risk Assessment System in France, Algeria, Morocco and Tunisia. The […]

FDA Advisory Panel Approves Novel Cholesterol-Lowering Drug

An advisory committee for the Food and Drug Administration has recommended the approval of a novel, injectable cholesterol-lowering drug called alirocumab, though many committee members have noted certain restrictions for its use and have requested further data on the drug’s ability to reduce the risk of heart problems. According to the Centers for Disease Control […]

First Biogen Inc, Now Roche Holding Ltd. : Rays Of Hope For An Alzheimer’s Cure

After Biogen’s success in slowing down Alzheimer’s progress in early-stage trials, Roche Holding intends to take its own Alzheimer’s candidate on a trial re-run Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) is considering the initiation of a second trial to test its investigational Alzheimer’s drug that was abandoned in December after a disappointing initial study, Bloomberg reports. […]

Insulin Produced in Constantine Available on Market in H1 of 2016

BOSTON (USA) – Saïdal Group Marketing Director Naili Saad-Eddine Yahia, said Saturday in Boston (USA) that the insulin produced in Constantine will be available on the national market in the first half of 2016. On the sidelines of the 75th Session of the American Diabetes Association, the same official said that Constantine insulin production plant […]

Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of adult patients with chronic hepatitis C genotypes (GT) 1, 4 or […]

Virotherapy: Skin Cancer Successfully Treated With Herpes-Based Drug

Virotherapy’ uses modified herpes virus to attack melanoma cells and has potential to overcome cancer even when disease has spread throughout the body. Patients with aggressive skin cancer have been treated successfully using a drug based on the herpes virus, in a trial that could pave the way for a new generation of cancer treatments. […]

Biomedical Research: Diagnosis of Deputies

The law N° 28-13, introduced in June 2014, was finally adopted by the chamber of deputies. The impact of this new legislation on the development of biomedical research was highlighted by the committee of social sectors. Members have declared the gap in the law that has long prevailed in this area and has negatively impacted […]

Algeria: Nearly DZD 180 Billion Devoted to 2015-2019 National Anti-Cancer Plan

Algiers — The overall cost of the 2015-2019 anti-cancer national plan has been estimated at nearly DZD 180 billion, according to a report on the plan presented Sunday at the Council of Ministers by the Minister of Health, Population and Hospital reform. “The total cost of the 2015-2019 national anti-cancer plan has been estimated at […]